Category : News/Events
Topic for the October 2020 Vaccine Dinner Club (VDC):
SARS-CoV-2 Vaccines Part II: Distribution Challenges
Think ahead for a minute to a halcyon future in which one or more pharma companies have reached the finish line in developing their SARS-CoV-2 vaccine. Their Phase III human trials are complete, their data have been parsed, their regulatory approvals have been secured, and enough glass vials and syringe needles to fill Shea Stadium (to REBUILD Shea Stadium) are in the process of being churned out.
So NOW what? Given that there is no way in the world that there will be enough vaccine to go around right at first:
- Who decides what countries should get the first shipments of vaccine?
- How is it decided what people in recipient countries should be on the short list for first dibs at a dose?
- What is it going to take to purchase, distribute, and deliver vast amounts of the vaccine to every remote spot on the planet it is needed? and
- What is it going to take to keep all those individual doses viable until they are needed?*
- William H. Foege, MD, MPH
- Capt. Janell Routh, MD, MHS
- Wednesday October 7, 5:20PM – 7:00PM via Zoom
- Advance registration is required in order to participate, click here to register for the October 7th meeting
- To learn more about the VDC, click here!